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Abstract 
Post-operative pain is accompanied with strong emotional and physical responses which 
may often discourage the healing process. Acute pain serves as a physical warning sign to 
the patient but when left unchecked, the acute pain process can increase nociceptor 
sensitivity and ultimately lead to chronic pain syndromes. Currently, it is thought that 
providing pain medication to block pain receptors prior to nociception might decrease the 
development of, or severity of, pain. Some practitioners have used ketamine as an adjunct 
pain medication perioperatively to decrease pain. The purpose of this review is to 
investigate the efficacy of Ketamine administered in a pre-hospital or pre-surgical setting 
on the overall pain management of surgical patients A literature search was performed on 
PubMed and Medline and using the PRISMA flowchart, and appropriate studies were 
identified. Each study was critically appraised and organized into tables to organize 
related variables and results. Variables included ketamine dosing, route of administration, 
the use of opioid or local anesthetic for comparison, type of surgery, and the length of 
duration into the post-operative period that pain scores were recorded. This systematic 
review supports that preemptive ketamine reduces acute pain in the immediate post-
operative period.  
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The Use of Preemptive Ketamine for Surgical and Trauma Patients: A Systematic 
Review  
Background/Statement of the Problem 
Alleviating pain and providing comfort is a cornerstone of nursing and medical 
practice. In recent years, the Institute of Medicine (IOM) has declared pain a public 
health problem costing society billions (Institute of Medicine [IOM], 2011). The IOM has 
placed a large emphasis on the quality of care, or the extent to which the services 
provided to the patient actually improve overall patient health (2011). The results of the 
delivered care should be optimized patient outcomes and this includes the management of 
pain. Not only does poor pain management lead to dissatisfied patients, but it also 
contributes to prolonged post-operative recovery and eventual long-term changes such a 
neuronal system remodeling and sensitization, chronic pain, and the stress response. This 
response includes increased blood clotting, impaired immune function, inflammation, 
lung and brain injury, breakdown of body tissue as well as a sympathetic response, or 
“fight or flight” (Hayes & Gordon, 2015).  
Due to an increased focus on patient-centered care and proper pain management, 
the use of measuring and reporting pain through various self-report or visual analogue 
pain scales has become common practice. The focus on patient-reported pain assessments 
have led to over-prescribing opioids by providers and contributes to the opioid epidemic 
(Hayes & Gordon, 2015). Historically, opioid medications (morphine and fentanyl) have 
been used as the medication of choice for pain relief. Due to the incidence of nausea and 
vomiting associated with these medications, their administration is often preceded or 
immediately followed by an antiemetic. Additional well-documented negative side 
effects of opioids include accidental overdose, hypotension, respiratory depression, and 
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loss of protective airway reflexes. In most prehospital trauma systems, opioids continue 
to be the analgesic of choice despite the narrow therapeutic range and potential for 
adverse outcomes (Losvik, Murad, Skjerve, & Husum, 2015). Recently, attention has 
shifted to the preemptive use of Ketamine as a safe and effective drug for pain 
management. Ketamine provides analgesia, amnesia, protects airway responses, and has a 
rapid onset for quick relief (Svenson & Abernathy, 2007).  
Despite the negative outcomes associated with the use of only opioids for pain 
relief, as well as emerging evidence that ketamine alone or in addition to opioids for pain 
relief may lead to lower pain scores and more stable physiologic results for the patient, 
morphine (opioids) remains the staple of pain relief in healthcare. The purpose of this 
review is to investigate the efficacy of Ketamine administered in a pre-hospital or pre-
surgical setting on the overall pain management of surgical patients. Data will be 
gathered from randomized controlled studies to examine the scientific evidence in favor 
for or against the use of ketamine for preemptive pain relief. The locations that data has 
been taken from include hospital settings prior to surgery. 
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Literature Review 
  
To examine this topic further, a literature search was performed using Pubmed 
and Medline. Search terms included: pain, preemptive analgesia, preemptive ketamine, 
trauma, and preoperative analgesia. The broad topic of the physiology of pain is first 
addressed, then current analgesic practices, and finally ketamine as an analgesic and why 
this drug shows promise as an opioid alternative.  
Pain  
Pain is a somatic sensation caused by tissue damage and is accompanied by 
emotional and psychological factors (Kelly, Ahmad, & Brull, 2001).  Nociceptors (pain 
receptors) located on skin, arterial walls, joint surfaces, as well as other areas, can be 
activated by mechanical, chemical, or thermal stimuli and then convert these stimuli into 
neural impulses. Type A delta fibers are responsible for fast pain transmission and type C 
nerve fibers are responsible for slow, chronic pain transmission. The damaged tissues 
release chemical substances such as prostaglandins, bradykinins, leukotrienes, substance 
P and free-radicals that serve to promote inflammation and sensitize these pain fibers 
leading to a state of hyperalgesia (Kelly, Ahmad, & Brull, 2001). Once the chemical 
release occurs, a pain-free state is often more difficult to attain.  
With a lack of adequate pain control, peripheral sensitization occurs first in which 
the body initiates the inflammatory process in the primary area of injury and immediately 
adjacent to the injury (Farris & Fiedler, 2001). The area of hyperalgesia amplifies 
nociception to thermal and mechanical stimuli. Central sensitization may occur later in 
which the central nervous system experiences a change in neuronal excitability in the 
spinal cord dorsal horn in which pain is sensed in the brain with even low-stimulation, a 
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phenomenon that can persist even after the primary injury has resolved (Farris & Fiedler, 
2001). 
Pain is a frequently encountered patient condition in the hospital and is often 
considered a normal part of the surgical and healing process. This ‘par for the course’ 
attitude leads to delayed or inadequate treatment that is often carried out via pro re nata 
(PRN), or ‘as needed’ pain medication administration scheduling traditionally with non-
steroidal anti-inflammatory drugs (NSAIDs) or opioid pain medication. Pain perception 
by the patient and providers is subjective and the correct course of action for treatment is 
unclear. When pain is left untreated, hyperalgesia, alterations in pain processing and 
chronic pain may ultimately develop (Kelly, et al., 2001).  Chronic pain may develop 
from acute post-operative pain in up to 50% of patients after surgeries such as 
amputations, breast surgery, or inguinal hernioplasty (Wegorowski, et al., 2016). 
Preemptive pain medication   
The negative outcomes of untreated pain can be avoided when an analgesic is 
administered before a painful stimulus, such as a surgical incision, to counteract 
sensitization in the first place. Preventing sensitization is the basis for preemptive 
analgesia. It has also been well documented that preemptive use of pain medication prior 
to the application of noxious stimuli results in better-controlled pain versus waiting to 
treat pain until the noxious stimuli has already occurred (Wegorowski et al., 2016). For 
example, prostaglandins and leukotrienes, when released from damaged tissue increase 
the transduction of painful stimuli by reducing the pain threshold of peripheral pain 
receptors and increasing their responsiveness (Kelly, et al., 2001). By inhibiting the 
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arachidonic acid pathway and blocking the formation of these chemical mediators, the 
pain enhancing effect of these inflammatory mediators might be prevented.   
A prospective study was conducted over a 6-month period with U.S. combat 
forces in Afghanistan using data collected on 309 casualties from the point of injury to 
arrival to surgical hospitals (Shackelford et al., 2015). The purpose of this study was to 
evaluate the current use of prehospital pain medications used by U.S. Forces in 
Afghanistan and to compare vital signs before and after pain medication administration. 
The authors found that prehospital pain medication administration to trauma patients with 
morphine, fentanyl or ketamine all resulted in decreased pain scores on a numerical scale 
upon arrival to the hospital and resulted in better overall pain management (Shackelford 
et al., 2015). The authors also found that when Ketamine was used for pain relief it 
resulted in a higher blood pressure (Shackelford et al., 2015). This effect of Ketamine 
proves to be advantageous in shock patients and supports the Defense Health Board’s 
recommendation that ketamine be used for analgesia in this specific patient population 
(Shackelford et al., 2015). Currently, ketamine is the first-line pain medication for 
casualties in shock or at risk for shock (Shackelford et al., 2015). Besides pain control, 
the preemptive use of pain medication has also been linked to a decrease in post-
traumatic stress disorder development among civilian and combat casualties (Shackelford 
et al., 2015).  
A double-blind study performed by Wegorowski et al. (2016) aimed to evaluate 
the effects of analgesics used pre-emptively on the level of post-operative pain intensity 
felt by female patients after surgical treatment of breast cancer. The study included 100 
patients with an average age of 59 years who had breast operations for breast cancer that 
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included simple and radical mastectomies, quadrantectomies, local excision and sentinel 
node biopsy. The patients were divided into four groups, three of which received 
preemptive analgesia (Metamizole, Tramadol, or Ketoprofen) prior to induction for 
anesthesia. One group received no pain medication. Data was collected at 6, 12, 18, and 
24 hours post-operatively. The authors found that patients had significantly less pain 
post-operatively when they received preemptive pain medication (in this case, tramadol 
or ketoprofen) than those patients who did not receive any medication, thus highlighting 
the effectiveness of preemptive pain medication on post-operative pain control 
(Wegorowski et al, 2016).  
Researchers Grube, Milad, and Damme-Sorenen (2004) conducted a randomized, 
double-blind study to explore the effect of preemptive analgesia in patients undergoing 
laparoscopic procedures and the degree of postoperative pain. The study, conducted from 
2000 to 2001, included 164 patients: 85 randomized to the study group receiving 
analgesia and 79 in the control group received no preemptive analgesia. The authors 
found that the overall mean pain scores and incisional pain scores did not differ at 4 hours 
post-operatively or 24 hours post operatively for both study and control groups. The 
results are contradictory to most available literature. The study found that preemptive 
analgesia did not reduce post-operative pain in this population (Grube, Milad, and 
Damme-Sorenen, 2004).  
Ketamine  
Ketamine is considered a dissociative anesthetic and works by blocking the N-
methyl-d-aspartate acid receptor and preventing the hyper-excitability of the spinal cord 
neurons and central sensitization to peripheral nociceptor stimulation (Oliveira, Sakarta, 
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& Martins, 2005). Preventing central sensitization is the main objective of preemptive 
analgesia. Studies have found that concentrations of ketamine in the brain were directly 
related to analgesic levels: using functional magnetic resonance imagining (fMRI), pain 
activation areas in the brain (somatosensory cortex, thalamus, anterior cingulate cortex) 
showed decreased activity when ketamine was given which correlates with a decrease in 
pain sensing and pain processing (Niesters, et al., 2012).  
Ketamine had also been found to possess activity at the µ receptor in rats and the 
κ receptor in guinea pigs suggesting a similar effect in human models (Smith, et al., 
1987). This theory has been supported by studies that have found that analgesia, when 
obtained via the use of ketamine, can be decreased when naloxone is given (Stella, 
Crescenti, & Torri, 1984). This phenomenon suggests the ability of ketamine to be used 
not only as an analgesic but also as an opioid-sparing drug. The ability of ketamine to 
decrease the amount of administered opioid to achieve pain relief has implications for the 
United States which is suffering from the over-used and over-prescribed opioid epidemic.  
Opioids have typically been the analgesic of choice for prehospital trauma pain 
relief. Opioids are not without harmful side effects that may be amplified in situations 
where a first responder is unable to provide uninterrupted monitoring. Decreased levels 
of consciousness can result from opioid use, whether in large doses or not, causing 
airway blockage and decreased oxygenation and this has been reported as a common 
cause of avoidable death in trauma patients (Tran, et al., 2014).  
Ketamine is a sympathomimetic and generally causes varying degrees of 
increased heart rate and blood pressure stability, it is considered preferable for use in 
trauma or shock patients and has been recommended by the Committee on Tactical 
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Combat Casualty Care as a first line analgesic (Shackelford, et al., 2015). Ketamine 
contrasts with opioids such as morphine in that patients with sub-anesthetic doses (but 
high enough for analgesia) can maintain their airway. Ketamine causes minimal 
respiratory suppression (Shackelford, et al., 2015). Some reported side effects of 
ketamine include nausea/vomiting, dysphoria, agitation, and disorientation.  
Preemptive Ketamine  
A retrospective study by Svenson and Abernathy (2007) was conducted to review 
the experience of the use of ketamine in a regional air ambulance setting. The authors 
found that pain relief for burn patients was only achieved with the addition of ketamine 
after already being treated with large doses of narcotics. The study took place from 
January 2003 to June 2006 and included 40 patients who were given Ketamine during the 
aeromedical evacuation program. Ages ranged from two months to seventy-five years old 
and included trauma, burn, cardiac and respiratory patients. The researchers found that all 
cardiac patients were hypotensive and required intubation to protect the airway but that 
after ketamine was administered blood pressure was maintained. Two patients were 
assessed to have difficult airways, so ketamine was administered for airway safety in 
place of narcotics. All patients that received ketamine for pain/sedation maintained 
airway responsiveness and oxygen saturations. The authors concluded that “ketamine is a 
safe and effective drug to use in the prehospital environment” and that there are a 
“variety of situations in which ketamine may be more appropriate than the current more 
common field medications” (Svenson & Abernathy, 2007, p. 978).  
A retrospective comparative study was conducted over a ten-year span in 
warzones in North and Central Iraq to investigate the effects of prehospital analgesia on 
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physiologic trauma severity indicators, specifically with the use of ketamine and 
pentazocine. This study included adult trauma patients 15 years and older and variables 
measured included blood pressure, respiratory rate, level of consciousness and injury 
severity as a reflection of pain. ISS scores of 75 are considered incompatible with life and 
these patients, along with patients scoring an ISS of one, were excluded from this study. 
The final sample study included 1,876 patients. Comparisons were done using ANOVA 
and associations were found using GLM linear regression model. Researchers found that 
in patients with an Injury Severity Score greater than 8 (moderate to severely injured) 
who received ketamine had significantly better physiologic outcomes and treatment 
effects than opioid use alone, including respiratory rate and blood pressure (Losvik, 
Murad, Skjerve, and Husum, 2015). The authors also found that receiving analgesia, 
whether narcotic or ketamine, was associated with a better blood pressure score but those 
patients with more serious injuries that received ketamine had a significant positive 
change in systolic blood pressure. Both narcotic and ketamine were associated with a 
negative impact on the level of consciousness. This study also showed that prehospital 
analgesia, narcotic or ketamine, was associated with an overall improvement of 
physiological severity indicators (Losvik, Murad, Skjerve, & Husum, 2015).  
Authors Johansson, Kongstad and Johansson (2009) conducted a prospective 
clinical cohort study in Sweden with 27 bone fracture patients who received either 
morphine or morphine with ketamine. Data was collected at the scene of rescue and then 
later at admission to the hospital and the data included level of pain, nausea/vomiting, 
systolic blood pressure, heart rate and oxygen saturations. The authors discovered that 
values for pain during admission to the hospital were significantly lower in the morphine-
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ketamine combination treatment group and that those patients delivered to the hospital 
after treatment for morphine alone were in moderate to severe pain according to the pain 
scores. The authors also concluded that adding low-dose ketamine to a standard morphine 
dose improves hemodynamics but that additional doses of ketamine will increase the 
incidence of nausea and vomiting.  
A prospective, cluster-randomized study conducted in rural Vietnam with 308 
patients aimed to compare the analgesic effects and side effects with the use of morphine 
and ketamine in prehospital trauma care. The average age was 36 years, most patients 
studied were male and suffered from road traffic accidents. Using the Visual Analogue 
Scale (VAS) for pain scoring, the authors found that ketamine yielded a comparable 
analgesic effect to that provided by morphine but that ketamine provided greater airway 
protection and less nausea/vomiting (Tran, et al., 2014).  
In summary, preemptive pain medication promotes positive health outcomes for 
patients. The use of ketamine as a preemptive analgesic is promising in that many 
individual studies demonstrate equivalent or superior analgesia with the added benefit of 
stable vitals and better airway control. Further study analysis follows.  
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Theoretical Framework 
 
Good’s middle-range theory of balance will be used to guide research and 
translate findings to real-life health care practices. The theory focuses on the balance 
between attaining a pain-free state versus the side-effects and poor outcomes of the 
medication used to achieve this state of analgesia (Fitzpatrick & Wallace, 2006). The 
theory includes the use of a multimodal approach to minimize the side effects of one drug 
but still to achieve analgesia, as well as frequent assessments for pain, side-effects and 
negative outcomes of the drug itself so that individual responses to medications can be 
managed (Fitzpatrick & Wallace, 2006). Good’s theory also includes patient participation 
and goal-setting to determine what is an acceptable level of pain per the patient so that 
complications from pain medication can be reduced 
In addition to Good’s middle-range theory, Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) was used as an evidence-based 
checklist and guideline for researchers in reporting and consolidating randomized-
controlled studies in the form of a systematic review. This is presented below in Table 1. 
This analytic framework helps to highlight common themes, outcomes of interest, and 
relationships between variables. The PRISMA checklist includes specific guidelines for 
what should be reported in each section of the systematic review, including rationale, 
objectives, eligibility criteria for studies, documentation of the search, synthesis of 
results, risk of bias in each individual study included, summary of all evidence, 
application, and conclusion (Moher et al., 2009).  
The purpose of PRISMA is to aid the reader in understanding the protocol and 
processes involved in selecting and appraising research articles. This is particularly 
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important for systematic reviews as these pieces of evidence are used in establishing new 
practices in the health care field (also known as evidenced-based practice) due to their 
rigor. Systematic reviews are based on pre-established guidelines and protocols that are 
designed for transparency, replicability and integrity. It is then easier for the reader to 
determine bias (Moher et al., 2009).  
Table 1 
PRISMA Checklist 
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The PRISMA four-phase diagram (Figure 1) lays out the literature search process 
itself. This diagram displays how the researcher selected the articles appraised for the 
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systematic review. In this way, the search may be replicated so that the inclusion of all 
relevant studies may be confirmed.  
 
 
From: Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic Reviews and Meta- 
Analyses: The PRISMA Statement. PLoS Med 6(7): e1000097. doi:10.1371/journal.pmed1000097 
 
 
Figure 1. PRISMA Flow Diagram 
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Method 
Purpose 
The purpose of this review is to investigate the efficacy of Ketamine administered 
in a pre-hospital or pre-surgical setting on the post-operative pain management of trauma 
and surgical patients.  
Inclusion/Exclusion Criteria 
 In selecting randomized controlled studies to include in this review, some 
limitations were set. Included in this study are randomized controlled trials of preemptive 
Ketamine usage in minimally invasive or major surgeries, elective or emergent surgeries, 
peer-reviewed studies and patients with American Society of Anesthesiologists (ASA) 
scores I-V. An assignment of ASA 1 score indicates a healthy patient. With each 
increasing score, the patient is considered to have an increasing number of uncontrolled 
comorbidities that ultimately may affect the outcome of the anesthesia itself. A 
classification of ASA V indicates a severely sick patient who will not survive without the 
operation but is not necessarily expected to tolerate anesthesia. An ASA V assignment 
indicates that poor outcomes from the procedure are expected.  
Exclusion criteria included studies performed greater than 10 years ago (before 
2008), and studies written in foreign languages.   Studies conducted with the pediatric 
population (children below the age of 18 years) were also excluded due to the lack of 
randomized controlled trials (RCTs) conducted in this population as well as the difficulty 
of determining the level of pain a child is experiencing due to low quality and inaccurate 
pediatric pain-assessment scales, particularly with self-report pain scales.  
Search Strategy 
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 A literature search was performed using Pubmed and Medline databases via the 
PRISMA guideline. An initial search for “ketamine” and “pain management” yielded a 
total of 1,366 articles. Additional searches were performed by adding keywords such as 
“prehospital”, “preoperative”, and placing limitations such as studies written in English 
and published in peer review journals. The articles were then narrowed down to 41 total. 
After excluding pediatric populations, studies completed prior to 2008, and including 
only randomized controlled studies, seven final articles were included in this review. 
Keywords used in this search were as follows: Ketamine, preoperative, prehospital, pain 
management, trauma, analgesia.  
Data Collection 
 A critical appraisal tool known as Critical Appraisal Skills Programme (CASP), 
was used to critically appraise each RCT included in this systematic review. This is 
presented below in Table 2. Through a 10-item checklist, the clarity of results, the 
validity and reliability of results and data collection, as well as the usefulness and real-
life application of the data was determined for each article. The data gathered from each 
study was collected, organized and separated into charts to delineate common themes or 
outcomes. The data tables help to determine whether the studies support or refute each 
other. 
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Table 2.  
Critical Appraisal Skills Programme (CASP) 
A) Are the results of the trial valid? Yes        Can’t Tell          No 
1. Did the trial address a clearly focused issue?  
2. Was the assignment of patients to treatments randomized?  
3. Were all the patients who entered the trial properly accounted 
for at its conclusion? 
         
4. Were patients, health workers and study personnel “blind” to 
treatment? 
 
5. Were the groups similar at the start of the trial?  
6. Aside from the experimental intervention, were the groups 
treated equally? 
 
B) What are the results?  
7. How large was the treatment effect?    
8. How precise was the estimate of the treatment effect?  
C) Will the results help locally?  
9. Can the results be applied in your context?   
10. Were all clinically important outcomes considered?  
11. Are the benefits worth the harms and costs?  
  
 
(Singh, 2013)
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Results 
Based on the inclusion criteria, a total of seven studies were included in this 
systematic review. Summaries of the studies, including a general description of design, 
sample, method, and results, are presented in the following paragraphs.  
To assess the effect of pre-emptive ketamine on post-amputation pain, authors 
Wilson, Nimmo, Fleetwood-Walker and Colvin (2008) conducted a randomized double-
blind study with 53 patients undergoing lower limb amputation (Appendix A.1). Patients 
assigned to group K received epidural bupivacaine 0.125% and racemic ketamine 3.3 
mg/kg/l via continuous infusion. Patient assigned to group S received epidural 
bupivacaine 0.125% and NaCl 0.9% via continuous infusion. Following surgery, the 
epidural infusion was maintained within a range of 10-20 ml/h as needed for adequate 
analgesia (defined as VAS ≤ 30). If the maintenance infusion was inadequate, boluses of 
10-15 ml were given. Analgesia was supplemented with paracetamol 1 gram every 6 
hours orally as needed. All epidurals ran for 48-72 hours and no other analgesic was 
provided. If all medications failed to provide adequate analgesia, the patient was removed 
from the study. The period of epidural analgesia, motor block, number of epidural 
boluses, average VAS scores and negative side effects were recorded. The authors used 
the incidence of stump pain and phantom pain as primary outcome measures.  
Statistical analysis was performed using Chi-squared analysis or Fisher’s exact 
test as appropriate. ANOVA was also used to compare nonparametric data. Using these 
methods to assess data, the authors found that both groups had improved postoperative 
analgesia when compared to the patients’ preoperative pain state (see Appendix B.1). 
Group K had significantly lower pain scores than group S and required less epidural 
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boluses during the in-hospital postoperative phase. Mean epidural infusion rate and 
duration were kept constant between the groups. There was no significant difference 
between motor blockade for the duration of the epidural infusion between the two groups. 
The overall analgesic drugs prescribed did not vary between groups. Phantom and stump 
pain assessed at 8 days, 6 weeks, 3 months, 6 months and 12 months did not vary 
significantly between the two groups. There was also no detectable frequency in attacks 
between the groups during this time-period. Side effects such as nausea, vomiting, 
confusion and sedation were low and incidences were similar between groups (Wilson, et 
al., 2008).  
This study by Wilson et al. met all criteria outlined in the CASP worksheet 
(Appendix C.1). The study was transparent with a clearly focused issue, randomized 
treatment groups and patient assignments, and all patients were properly accounted for 
from beginning to end of trial. This study was easy to follow. Results can be applied to 
the clinical setting and all clinically important outcomes were considered.   
Researchers Behdad, Hosseinpour, and Khorasani (2011) evaluated 80 adult male 
patients undergoing an operation for acute appendicitis to determine whether the 
preemptive use of ketamine decrease post-operative pain (Appendix A.2). Patients were 
randomly divided into two groups. In the operating room, the ketamine group received 
0.5 mg/kg of ketamine IV 10 minutes prior to surgical incision. The control group 
received 0.5 mg/kg normal saline IV. All patients were pre-medicated with midazolam 
0.05 mg/kg IV. Patients were then induced with thiopental 6 mg/kg and atracurium 0.5 
mg/kg. For maintenance, isoflurane 0.5-1%, 50% nitrous oxide, and 50% oxygen were 
used.  Using the VAS, pain intensity was assessed at time 0 (immediately after arousal), 
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4, 12, and 24 hours post-operatively. The time interval for first request of analgesia was 
recorded as well as total number of times additional analgesia was requested in PACU 
during the first 24 hours. This information stated above is presented in Appendix A, table 
A.2. 
Behdad, Hosseinpour, and Khorasani (2011) found that for all evaluated post-
operative times, the VAS scores were significantly lower in the ketamine group 
compared to the control group. The interval time to first analgesic request was also longer 
in the ketamine group than the control group. 42.5% of the patient in the ketamine group 
did not require any addition analgesic post-operatively. Data are presented in Appendix 
B.2.There were no drug side effects in the ketamine group. Data were presented as mean 
standard deviation for quantitative variables. The Mann Whitney test was used to 
compared VAS scores across groups, as well as the time for first analgesic and total 
amount of analgesic. Statistical analysis was done with SPSS 11.5 (SPSS Inc., Chicago, 
USA). A P-value less than 0.05 was considered significant.  
To critique this article, the CASP checklist for randomized control trials was used 
(Appendix C.2). The authors clearly defined the issue of post-operative pain for acute 
appendicitis. The assignment of patients to treatment groups was randomized and the 
surgeon and research physician responsible for data collection were unaware of the 
patient assignment. All patients were accounted for in the study (there were no dropouts). 
Basic variables of the patients were illustrated in a table showing consistency in both 
groups with age, duration of surgery and duration of anesthesia. Aside from the 
experimental intervention, it was unclear whether both groups were treated equally. 
Anesthetically, induction medications were consistent between groups as well as 
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maintenance medications. However, surgically the authors only stated that a Mcburney 
incision for the appendectomy was performed. It is unclear whether further surgical 
variation occurred from patient to patient. The results are applicable clinically to this 
treatment group, and important outcomes were considered including side effects. 
Midazolam was appropriately given to all patients to avoid any side effects of the 
ketamine treatment, so harm to the patients was dutifully avoided (Behdad, Hosseinpour, 
& Khorasani, 2011).  
Researchers Ryu, Lee, Kim, and Bahk (2011) examined the effect of preemptive 
low-dose thoracic epidural analgesia on the incidence of chronic post-thoracotomy pain 
by conducting a prospective, double-blinded, randomized controlled trial (Appendix 
A.3). 133 patients were enrolled ranging from 19 years of age to 81 and using an Excel 
program-generated randomization table, the patients were randomized into two groups. 
Group KF (Ketamine-free) received thoracic patient-controlled epidural analgesia with 
0.12% levobupivacaine and 2 mg/mL of fentanyl making up a total volume of 500 ml. 
Group K (Ketamine) received the same epidural infusion with additional 100 mg 
preservative-free ketamine at 0.2 mg/ml concentration. For both groups the epidural 
infusion was programmed to administer a loading dose of 6 ml, a background infusion of 
6 ml/hr, and a bolus dose of 0.5 ml (on demand) with a lockout interval of 20 minutes. 
Both groups received the loading dose immediately upon arrival to the operating room 
where the adequacy of the block was verified. Then, both groups underwent general 
anesthesia using similar medications and dosing for induction and intubated with either 
double-lumen tubes or uninvent tubes. Maintenance of anesthesia was done using 1 to 1.5 
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MAC of sevoflurane or desflurane.  One surgeon performed all the procedures to provide 
consistency with surgical technique and approach (Appendix A.3).  
Pain at two weeks and three months post-operatively was measured at rest and 
during coughing using the VAS score. The presence of allodynia and numbness at the 
thoracotomy scar was also recorded. Using the Stata IC 10, a sample size of at least 65 
for each group was needed to prove statistical significance with data results. Statistical 
analysis was performed using Stata IC 10, 2-sample t test, and Fisher exact test to 
compare data between the two groups. A P value of less than 0.05 was considered 
significant. In the data collection table (Appendix B.3), all P values are higher than 0.05. 
Therefore, the authors concluded that low-dose ketamine, when added to thoracic 
epidural analgesia, did not make any significant difference in the incidence of post-
thoracotomy pain. Preemptive ketamine also did not have a measurable effect on the 
incidence of allodynia or numbness at 3 months after surgery. This data is presented in 
Appendix B.3. 
The CASP checklist was used to select this article for review (Appendix C.3). In 
this clinical trial, the authors clearly addressed the clinical problem, illustrated the 
selection and exclusion of patients, indicated that all health workers and study personnel 
were blind to the treatment, and outlined the general anesthesia and surgical process to 
emphasize consistency throughout the trial. Both experimental groups were similar at the 
start of the trial. Side effects of the epidural and any additional analgesic drugs used were 
not discussed. The results of this study can only rule out the use of low-dose ketamine as 
beneficial. Higher doses of ketamine might have produced significant results that would 
be relevant and applicable clinically.  
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Singh et al. (2013) performed a double-blinded randomized trial to evaluate the 
efficacy of preemptive analgesia using intravenous ketamine 30 minutes prior to surgical 
incision in patients undergoing laparoscopic cholecystectomy (Appendix A.4. This study 
used 80 adult patients of both female and male gender and ASA values of I or II. Patients 
were placed into one of four groups with 20 patients each. Group A received ketamine 
1.0 mg/kg, Group B patients received ketamine 0.75 mg/kg, Group C patients received 
0.50 mg/kg and Group D received isotonic saline only. All doses were diluted in fixed 
volumes of 10 mL for each patient. All patients received the same pre-operative 
medications. The same drugs, procedure for induction, and maintenance of anesthesia 
was also held constant for each patient across groups. Patients were then extubated prior 
to transfer to the PACU (Appendix A.4).  
In the PACU, patients were observed for pain intensity and relief using the visual 
analogue scale (VAS) and the verbal rating scale (VRS). These scores were obtained 
every half hour for two hours, every one hour for the following four hours, at 12 hours 
post-operatively and 24 hours post-operatively. Each time scores were recorded, the 
patient was evaluated at rest, at slight movement, and at deep breathing. Supplemental 
analgesia was administered using IV boluses of 1 mcg/kg Fentanyl when patient 
requested to allow comparison of opioid consumption between groups 24 hours post-
operatively. Adverse effects associated with medication were also recorded such as 
nausea, vomiting and hallucinations. The sample size of 20 patients per group gave a 
power of 80% at an α- level of 0.05. Using the SPSS statistical program (SPSS Inc., 
Chicago, IL, USA), t-test and analysis of variance test, data of the different groups were 
compared. The Chi-square test was also complete for analysis of qualitative data. Fisher’s 
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exact test was used to analyze the incidence of side effects and number of patients 
receiving rescue analgesic (Singh et al., 2013). This is located in Appendix B.4. 
The authors found the average VAS scores were significantly higher in Group D 
immediately after surgery (0 and 0.5 hours post-operatively) as well as hours 3, 4, 5, 6, 
and 12 when compared to all other groups at rest (Appendix B.4). VAS scores between 
groups A, B, and C at 0, 0.5, 1.0, 1.5, and 2 hours post-operatively were comparable with 
no significant variation. VAS scores at hours 1, 1.5 and 2 post-operatively were 
comparable in all four groups. VAS scores on deep breathing were higher than VAS 
scores recorded at rest and slight movement across all groups. Overall, the authors 
concluded that the VAS scores and total opioid consumption were higher when compared 
to Groups A, B and C at most of the time intervals. The mean time to rescue analgesia 
was significantly longer in Groups A, B, and C. The incidence of nausea and vomiting 
were comparable across all groups. Hallucinations occurred in 10% of subjects in Group 
A and 0% in all other groups (Singh et al., 2013).  
A critical evaluation of the Singh et al. (2013) study using the CASP worksheet 
found that the authors met all criteria presented. This is presented in Appendix C.4. The 
authors clearly identified the issue with thorough background information. Patients were 
randomly assigned to groups and accounted for throughout study. The authors stated that 
the demographic profile was statistically comparable between groups and all study 
personnel were blind to treatment groups. Materials and methods were detailed enough as 
to determine that all groups were treated equally. The results are relevant to surgical 
settings and all clinically important outcomes were considered, including side effects of 
medications (Appendix C.4).  
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Authors Jennings et al., (2014) conducted a long-term prevalence study of a 
randomized controlled trial examining the use of ketamine versus morphine for 
prehospital traumatic pain (Appendix A.5). A total of 97 patients were followed from 
December 2007 to July 2010. Patients were randomly assigned to one of two groups and 
received either a ketamine bolus of 20 mg intravenously followed by 10 mg every 3 
minutes, or if allocated to the morphine group the patient received 5 mg intravenous 
morphine every 5 minutes. Both groups were treated until pain free. After discharge from 
the hospital, the patients were contacted by telephone within 6-12 months. During the 
interview, the researchers used the Physical Component Summary (PCS), the Mental 
Component Summary (MCS), and the Verbal Numerical Rating Scale (VNRS). The PCS 
and MCS scales assess the perceptions of pain, energy, mental health, social functioning, 
and any physical limitations of the patient. The PCS and MCS scores between the two 
groups were compared using the two-sample t test for continuous variables. Numeric pain 
scale data were compared using the two-sample Wilcoxon rank-sum test. Treatment 
effects were considered significant at 0.05. 
 The researchers concluded that there was no significant difference in the long-
term follow-up between study groups despite citing evidence from previously conducted 
studies demonstrating that early analgesic interventions reduce the incidence of chronic 
pain after surgery. Of significance in this study was that a total of 45% of participants 
from both groups reported persistent pain because of their surgical injury. This 
information is presented in Appendix B, Table B.5. 
 Using the CASP worksheet to critically evaluate this study found that the authors 
met all but one criteria (Appendix C.5). Patient assignments were randomized, all 
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patients were accounted for from beginning to end, patients and personnel were blind to 
treatment and the groups were all treated equally. The authors did address that not all 
clinically important outcomes were considered, and that “time to treatment” data was not 
available to the researchers. The authors stated that this covariate may have been an 
important consideration when looking at clinically important outcomes. The results of 
this study can be applied to a clinical context, having this addition information would 
have made stronger results.  
In a prospective, double-blind randomized controlled study, Khashan et al. (2016) 
examined the effect of preemptive intra-articular morphine and ketamine on pain after 
arthroscopic rotator cuff repair (Appendix A.6). 45 patients, male and female, above 18 
years of age participated. All participants had partial or complete rotator cuff tears. Three 
groups of 15 each were created with each group receiving an allotted treatment 20 
minutes prior to surgery via intra-articular injection (20 mg or morphine, 50 mg ketamine 
and 10 mg of morphine, or 10 mL of 0.9% saline). All medications were injected in the 
subacromial space with the same technique using an 18-gauge needle. Standardized 
general anesthesia was then performed for each patient in beach chair position. Initial 
vital signs were recorded in PACU as well as pain scores via the Numeric Rating Scale 
(NRS). In PACU, all patients were hooked up to intravenous patient-controlled analgesia 
pumps (PCA) that delivered 1.5 mg morphine for each bolus with a seven minute lockout 
time. Oral paracetamol 1,000 mg and oxycodone 5 mg were also available to all patients 
upon request every six hours.  
Pain scores were evaluated every 30 minutes in PACU and every eight hours on 
the orthopedic floor by blinded nurses. Secondary outcomes of this study included the 
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amount of PCA morphine used by each patient as well as the amount of requested rescue 
medication use. Post-discharge pain levels and drug consumption were reported using a 
daily pain diary over the next three months. One-way analysis of variance (ANOVA) was 
used to compare numeric scale parameters between the three groups.  The authors found 
that PACU and three-month post-discharge NRS scores were comparable between the 
groups. The combined ketamine and morphine group’s pain scores were not statistically 
different from the other groups. Second week post-op pain scores declined significantly 
in the morphine-only and saline-only group. The NRS scores were significantly lower in 
the morphine-only group than the saline-only group during the time spent on the 
orthopedic floor and the first two weeks postoperatively. The authors concluded that 
preoperative intra-articular injection of ketamine and morphine did not produce 
preferable responses to pain relief versus morphine alone. Rescue analgesic consumption 
between all three groups also supported this conclusion. This data is presented in 
Appendix B, Table B.6. 
Critical evaluation of the Khashan et al. (2016) study using the CASP worksheet 
found that ten of eleven specific criteria were met. The authors clearly defined an issue 
within healthcare and detailed the blinding process throughout the study, as seen in 
Appendix C.6. The authors accounted for all the enrolled patients in the clinical trial via 
an illustrated flowchart. The groups were held to the same inclusion and exclusion 
criteria as clearly stated within the study. Although stated by the authors that 
“standardized general anesthesia” was administered, it is unknown how adjuvant 
analgesia administered intra-operatively varied from patient to patient. The results of this 
study are relevant to surgical environments with orthopedics.  
28 
 
Researchers Lin and Jia (2016) conducted a randomized, prospective, double-
blinded study with 90 patients scheduled for elective laparoscopic surgery to evaluate the 
effects of intravenous ketamine on visceral pain (Appendix A.7). Preoperatively, patients 
were trained for use of the visual analogue scale (VAS) and then randomly assigned to 
one of three groups. Group 1 received an intravenous placebo, normal saline. Group 2 
received preincision normal saline intravenously as well as local infiltration with 80 mg 
ropivacaine at the end of surgery. Group 3 received preincision ketamine 0.3 mg/kg and 
local infiltration with 80 mg ropivacaine. All groups received injections of equivalent 
volume. The anesthetic and surgical techniques were all standardized between patients of 
all three groups. Patients were then brought to PACU where assessment of parietal pain 
and visceral pain was initiated using the VAS.  
Parietal pain is defined as superficial pain on the abdominal wall and visceral pain 
is defined as deep, dull pain deep inside the abdomen. VAS scores were obtained at 2, 6, 
12, and 24 hours postoperatively. Shoulder pain was also recorded. A standardized 
method to treat post-operative pain using tramadol and meperidine based off severity of 
the VAS score was used. Quantitative data was compared between groups by analysis of 
variance and post-hoc testing. Statistical significance was assumed if P> 0.05. Qualitative 
data between groups was analyzed using the chi-square tests. The Statistical Package for 
Social Sciences (SPSS, Inc., USA) was used for statistical analysis (Lin & Jia, 2016).  
The authors Lin and Jia (2016) found that the VAS scores for visceral pain in 
group 3 were significantly lower than the pain scores in groups 1 and 2 at 2 and 6 hours 
post-operatively. This data is presented in Appendix B.7. Groups 1 and 2 showed no 
statistically significant difference in pain scores at hours 2 and 6. At hours 2 and 6, the 
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VAS scores were similar between groups 2 and 3 and both groups had significantly lower 
scores than group 1. All groups were comparable with visceral and incisional pain scores 
at 12 and 24 hours post-op. The time to first analgesic request was also documented in 
PACU. These scores were comparable in groups 2 and 3 which were both significantly 
longer than the times recorded for group 1. Group 1 also received higher doses overall of 
meperidine than the other groups. Differences in total analgesic consumption between 
groups 2 and 3 did not reach statistical significance. It was also noted that the incidence 
of post-operative nausea and vomiting was similar in all three groups (Lin & Jia, 2016).  
The CASP checklist for randomized control trials was also used to critique this 
study (Appendix C.7). The trial clearly defines the issue of postoperative visceral pain 
after laparoscopic gynecological surgery. The authors clearly state that patients were 
randomized to treatment groups and outlined patient characteristics (age, ASA category, 
weight, duration of surgery) across groups to illustrate no statistically significant 
difference. Authors Lin and Jia (2016) also accounted for all patients who entered the 
trial: of the 90 patients enrolled, two were excluded due to the need to place an intra-
abdominal drain in one and the need for conversion to an open procedure for another 
patient. Groups 1-3 had 29, 29, and 30 patients complete the study, respectively. Standard 
anesthetic and surgical techniques were outlined and similar across all groups. Clinically 
important outcomes were considered, including side effects. The results are applicable to 
clinical care of similar patients.  
Cross-Study Analysis 
 All studies included for analysis were randomized controlled trials. The study 
conducted by Jennings et al. was the only long-term follow up randomized controlled 
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trial to investigate the effects of preemptive ketamine on pain six to twelve months after 
treatment. Descriptive data synthesis of the included studies is illustrated in Appendix D. 
All studies included a large enough sample size to determine statistical significance (p < 
0.05). The variables across studies included the dosing of ketamine itself, the route of 
administration of ketamine, and the length of time into the post-operative period that pain 
scores were recorded. 
Four of the collected studies investigated the use of intravenously administered 
ketamine. When examining ketamine dosing, the Singh et al. (2013) study is the only 
included study that addressed the variability of ketamine dosing itself. Using doses of 
ketamine in descending order, Groups A, B and C (respectively) all reported significantly 
decreased pain scores and decreased opioid consumption in the post-operative period. 
Group D who received isotonic saline reported the highest pain scores. There was no 
difference between average pain score of the three groups indicating that increased 
ketamine dosing is not always more effective at relieving pain and that there might be a 
ceiling effect in terms of pain control. In fact, Singh et al. (2013) found that Group A 
with the highest dose of ketamine at 1.0 mg/kg reported the most side effects, such as 
high blood pressure, tachycardia, and hallucinations. This is significant for all other 
studies included in this systematic review because all other studies compared only one 
dose of ketamine with a control group using isotonic saline or another drug in a separate 
analgesic class. This suggests that using different doses of ketamine may not have 
necessarily altered pain scores in the other studies. The Singh et al. (2013) study reported 
administration of the highest intravenous dose of ketamine at 1.0 mg/kg, suggesting that 
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doses lower than this are appropriate for pain relief as well as decreasing adverse side 
effects. 
The second variable examined across studies was the route of administration. 
Intravenous, epidural and intra-articular administration is compared in the following 
paragraphs. The Behdad, Hosseinpour and Khorasani (2011) study used only ketamine 
and isotonic saline, intravenous, as their primary pain interventions. Like the Singh et al 
(2013) study, there was no comparison of the efficacy of ketamine to a local anesthetic or 
opioid. Both studies yielded similar results in that the groups treated with ketamine had 
significantly lower pain scores than their isotonic solution counterparts and they both 
discovered that total opioid consumption in the post-operative period was less in the 
ketamine-treated groups.  
Researchers Lin and Jia (2016) also investigated the effects of preemptive 
intravenous ketamine on post-operative pain in women undergoing elective 
gynecological laparoscopic surgery. The researchers found that group three who received 
local infiltration with ropivacaine and IV ketamine had significantly lower pain scores 
post-operatively than group two (local infiltration with ropivacaine alone) or the control 
group one (IV normal saline only) (Lin & Jia, 2016).  The authors also reported that 
consumption of additional analgesics was significantly higher in group one. Like authors 
Behdad, Hosseinpour, and Khorasani (2011) and Singh et al. (2013), Lin and Jia (2016) 
concluded that IV ketamine is effective in producing post-operative pain relief when 
compared to no intervention or local infiltration alone up to six hours post-operatively.  
Jennings et al. (2014) researched long-term post-operative pain with intravenous 
ketamine versus intravenous morphine given on hospital arrival to patients who sustained 
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musculoskeletal trauma. Jennings et al. (2014) found that the prevalence of pain, as 
measured by the Physical Component Scale (PCS), the Mental Component Summary 
(MCS) and the Verbal Numeric Rating Scale (VNRS) were approximately the same in 
the ketamine-treated group versus the morphine group. 46% of respondents stated there 
was persistent pain in the morphine group and 44% of respondents in the ketamine group 
(Jennings et al., 2014). Researchers in this study concluded that there was no significant 
difference in long term post-operative pain scores in patients treated with IV ketamine 
versus IV morphine.  
Two of the studies used in this systematic review were conducted looking at pre-
emptively modulating central sensory input via ketamine administration by the spinal or 
epidural route. Wilson et al. (2008) used this approach when studying the effects of 
preemptive ketamine on lower limb amputations. Wilson et al. (2008) found that 
ketamine, when administered with bupivacaine infusion in a combined spinal-epidural 
anesthetic, yielded similar pain relieving results as a combined spinal-epidural with 
bupivacaine alone: the pain-relieving effects between groups did not differ. In addition, 
the overall number of analgesic drugs administered post-operatively in both groups was 
similar, and at 12 months post-operatively the number of analgesic drugs prescribed was 
the same for both groups.  
 Researchers Ryu, Lee, Kim and Bahk (2011) investigated epidurally 
administered ketamine on post-thoracotomy pain and found that it did not improve pain 
with movement or rest at two weeks or three months post-operatively any more than an 
epidural administered without ketamine. There was also no difference in chronic post-
thoracotomy pain, allodynia, or numbness at three months after surgery between both 
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groups. Both studies concluded that ketamine, when given with spinal or epidural 
administration, did not provide any additional reduction in pain when compared with 
traditional local anesthetic/opioid combination.  
Kashan et al. (2016) conducted a study looking at preemptive intra-articular (IA) 
ketamine-morphine cocktail (KM) versus morphine (M) alone and saline (S) alone on 
post-operative pain management in patients undergoing arthroscopic rotator cuff repair. 
Researchers found that in the first 14 post-operative days, group M’s pain scores did not 
differ significantly from group KM’s values, but both groups had significantly lower pain 
scores than control group S. The three month pain scores did not differ significantly 
between group M or group KM. Kashan et al. (2016) concluded that preoperative intra-
articular administration of ketamine was not superior over the use of morphine alone. 
Kashan et al. also stated that neither IA morphine nor IA ketamine were effective in 
longer-term post-operative pain management.  
A third common variable between the studies included the time in the post-
operative period that data collection began. Behdad et al. (2011) found that IV ketamine 
at a dose of 0.5 mg/kg was effective at relieving pain up to 24 hours post-op when 
compared to no other analgesic. Singh et al. (2017) found that pain scores were highest in 
the group that did not receive ketamine for 24 hours post-operatively. Authors Lin and Jia 
(2016) found that IV ketamine was also effective at relieving post-op pain, but only for 
visceral pain up to six hours post-operatively. The researchers found that the pain scores 
began to equalize at the 12 and 24-hour post-operative mark when gathering data (Lin & 
Jia, 2016). This suggests that intravenous ketamine, when administered preemptively for 
post-operative pain relief, may only have a limited window of effectiveness in the post-
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operative period, possibly only up until 24 hours. Examining the Jennings et al. (2014) 
study, the authors investigated long-term pain prevalence and found no statistically 
significant difference between the ketamine group and morphine group when data 
collection started six months post-operatively. This study illustrates that IV ketamine is 
not effective in managing chronic post-operative pain which is consistent with the 
findings of the other studies looking at IV ketamine and the lack of efficacy in the 
treatment of long-term or chronic pain. This differs from the aforementioned studies 
using intravenous ketamine who obtained data in the acute post-operative period and 
found that ketamine had positive effects on pain relief.   If Jennings et al. began data 
collection sooner, results may have been different.  Wilson et al. (2008) stated epidural 
ketamine was ineffective for managing post-operative pain but the researchers only began 
data collection on post-operative day eight. It is possible, like the previously mentioned 
intravenous studies demonstrated, that ketamine may have had an effect on the acute pain 
felt in the immediate post-operative period. To determine this, data collection would need 
to begin in the post-operative care unit (PACU). Ryu et al. (2011) were unable to 
determine whether ketamine had a significant impact on post-operative pain relief. 
Researchers for this study began data collection two weeks into the post-operative period 
again indicating that they may have missed the therapeutic response to acute pain. This 
study and the Wilson et al. (2008) study suggest that, like intravenous ketamine, epidural 
ketamine is ineffective for chronic pain management. Epidural ketamine’s effects on 
acute pain is still undetermined and would require further research.  
Khashan et al. (2016) was the only study examining intra-articular administration 
of ketamine. Pain scores were obtained in the acute post-operative period in PACU as 
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well as into the chronic pain period. The researchers did not find any benefit to the 
addition of ketamine for pain relief, regardless of time frame of data collection.  
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Summary and Conclusions 
Surgical trauma incites nociceptive pain sensitization and this acute pain, when 
left untreated or undertreated, can develop into chronic pain long term (Wegorowoski et 
al., 2016). The mechanism by which this occurs isn’t fully understood, but peripheral 
signaling of tissue damage and pain ultimately can lead to altered central pain processing 
and development of chronic pain or hyperalgesia states (Kelly, Ahmad, & Brull, 2001). 
The idea of pre-emptive pain management involves thwarting the development of central 
sensitization in the first place. By using multi-modal pain medication, multiple pain 
pathways might be modified or blocked allowing for a more complete and thorough pain-
free state (Wegorowoski et al., 2016). This includes local anesthetics, opioids, non-
steroidal anti-inflammatories, mediating the GABA response, and NMDA-receptor 
antagonists. Multi-modal therapy approaches cover a wider-range of pain transmission 
and lessen the side effects of any one drug (Kelly, Ahmad, & Brull, 2011). Recent 
interest in the NMDA receptor as a target for substance P in pain transmission in the 
dorsal horn has turned some focus onto the use of Ketamine (an NMDA-receptor 
antagonist) as an adjunct or alternative pain medication. By blocking “wind-up” in the 
dorsal horn, this may decrease pain transmission and central sensitization and lessen the 
chance of chronic pain development (Kelly, Ahmad, & Brull, 2011).  
The purpose of this review is to investigate the efficacy of Ketamine administered 
in a pre-surgical setting on the post-operative pain management of surgical patients. 
Outcomes were assessed with pain scores and total amount of additional analgesic 
requested. A comprehensive literature search was performed and the Preferred Reporting 
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Items for Systematic Reviews and Meta-Analyses (PRISMA) flowchart was used to 
identify applicable studies that might be included or excluded (Moher et al., 2009). Each 
of the included studies was critically appraised using the Critical Appraisal Skills 
Programme (CASP) illustrated in Table 2. The basics of each study, the variables and 
outcomes as well as the individual CASP is illustrated in charts located in Appendices A, 
B and C. Lastly, a cross-study analysis was done to examine and compare key variables 
and outcomes. This is located in Appendix D.  
 Overall, low-dose intravenous ketamine used preemptively can decrease pain 
scores and additional analgesic/opioid consumption in the immediate post-operative 
period.  This is supported by Lin & Jia (2016), Singh et al. (2017), and Behdad et al. 
(2011). The researchers found that this was effective at least up until six hours post-
operatively and in some cases up to 24 hours post-op. Jennings et al. (2014) was the only 
study using intravenous ketamine that found that it was not superior in terms of pain 
relief to the control group. The study compared IV ketamine to another IV analgesic 
(morphine). The researchers also looked at the effects of ketamine on long-term pain and 
began to data collect at six months post-op. Jennings et al. (2014) were able to conclude 
that ketamine provided similar analgesia in the long-term post-op period as morphine, but 
neither were very effective.  
Morphine and ketamine work by different mechanisms (mu receptor and NMDA 
receptor respectively) and can be used in conjunction. These drugs also have different 
side effect profiles and therefore may be more or less appropriate for certain patient 
populations. A limitation of the Jennings et al. (2014) study was the loss of data due to 
lack of follow-up from participants. Long-term follow-up was only completed for 72% of 
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the participants which may affect the study’s validity. Looking at the characteristics 
profile of the patients who responded and the patients who did not respond to surveyors, 
there is little difference (Jennings et al., 2014). Another consideration is that data 
collection began at six months post-op: if data were collected in the immediate post-
operative period (24 hours or less), would ketamine have been found to be a more 
effective analgesic? 
 There is a distinction between acute and chronic pain. The Jennings et al. (2014) 
study examined preemptive pain relief in determining the effect on chronic pain. Chronic 
pain is defined as pain outlasting the normal time of healing and becomes a disease state 
itself (Grichnik & Ferrante, 1991).  The other three studies examining preemptive 
intravenous ketamine collected pain scores in the acute setting. Acute pain is the result of 
a specific injury (surgery) and serves a biological purpose (Grichnik & Ferrante, 1991). 
To determine if preemptive intravenous ketamine is effective in preventing chronic pain, 
more studies would be needed.   
 There were several limitations associated with this systematic review. The route 
of administration of ketamine varied as well as the dosages. Some dosages were flat 
numbers and remained consistent between patients while other dosages were weight-
based and therefore variable between patients. The types of surgeries also varied, so the 
level of pain stimulation was not consistent across studies: different healing times and 
post-operative pain levels would be expected. These variations made comparisons 
difficult. Additionally, some researchers reported side effects (whether negative or 
positive) in the discussion of their research while others did not consider it an integral 
part in reporting the results.  
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 In summary, this systematic review supports the cautioned use of intravenous 
ketamine in adult surgical patients to manage short-term acute pain. More studies are 
needed to determine the effectiveness of epidural ketamine on acute post-operative pain. 
Further, the use of intra-articular ketamine may be effective, but not superior to 
morphine. The use of ketamine in the management of long-term pain requires more 
research but did not prove effective in this systematic review for any route of 
administration.  
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Recommendations and Implications for Advanced Nursing Practice 
 The purpose of a systematic review is to discuss and critically analyze controlled 
trials testing similar subject matter as that found in a clinical setting.  By comparing 
findings from the studies, information can be synthesized to guide clinical practice and 
decision making. Pre-emptive ketamine is currently controversially used in clinical 
practice for pain prevention and treatment. This practice is not well defined including 
different routes of administration, different doses and different times of administration in 
the perioperative period. Further research on the use of ketamine in the clinical setting, 
administration and effectiveness via different routes, and the effect on pain will help 
educate medical practitioners and guide them to better decision-making for improved 
patient outcomes.  
 Although ketamine cannot definitively be recommended to prevent acute pain 
post-operatively, it does show positive results in reducing pain when administered 
intravenously, epidurally, or intra-articularly with an adjunct or used alone. Intravenous 
ketamine did show a more consistent and precise improvement in pain scores than 
ketamine administered via epidural or intra-articular routes. However, these alternative 
routes of administration should not be ruled out as they also yielded pain relief: further 
research on proper dosing and timing of epidural and intra-articular ketamine 
administration is needed.  
These findings relate back to Good’s middle range theory on pain management 
which calls for a multimodal pain approach to allow for maximal coverage of pain 
receptors and decreased negative side effects associated with excessive use of any one 
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medication. Of the studies that reported side effects, no study reported an increase of 
negative side effects with the addition of ketamine to an opioid or local anesthetic. The 
Singh et al. (2013) study supports the use of multimodal pain management for more 
effective pain relief and decreased side effect profile. Group A who received the highest 
dose of ketamine had no further pain relief but a 10% incidence of hallucinations whereas 
all other groups reported no hallucinations (Singh et al., 2013). In fact, Wilson et al. 
(2008) reported a noticeable decrease in depression levels up to one year after treatment 
in patients with lower limb amputations when compared to the control group without 
ketamine. The application of this research to the clinical setting may allow for improved 
post-op pain control, decreased opioid consumption, and decreased side effects of opioid 
consumption (such as nausea, vomiting, constipation, hypersensitivity, dependence, and 
sedation). While ketamine did not prove to be effective in preventing chronic pain, 
multimodal approaches should continue to be researched for application in the clinical 
setting.  
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Appendix A 
Study Descriptions 
Table A.1  
Wilson, J., Nimmo, A., Fleetwood-Walker, S., & Colvin, L. (2008). A randomized double blind trial of the effect of the pre-emptive 
epidural ketamine on persistent pain after lower limb amputation. Pain, 135, 108-118.  
Aim 
 
To assess the effect of 
preemptive treatment with 
an epidurally administered 
NMDA receptor antagonist, 
ketamine, in combination 
with local anesthetic, on 
reducing spinal sensory 
transmission, acute central 
sensitization and the 
development of persistent 
post-amputation pain.    
Design 
 
Double blind, 
randomized control 
trial. 
 
Group K- 0.125% 
bupivacaine with 
3.3 mg/kg/L 
ketamine via 
epidural infusion 
 
Group S- 0.125% 
bupivacaine with 
0.9% saline via 
epidural infusion 
 
Mean epidural 
infusion rates and 
duration was the 
same for both 
groups.  
 
 
 
Site 
 
Royal 
Infirmary of 
Edinburgh, 
Scotland 
Sample 
 
47 total patients 
included in the 
study, 21 patients 
in Group K, 26 
patients in Group 
S.  
 
VAS* scores were 
similar between 
groups pre-
operatively.  
 
Patients excluded 
from the study 
included patients 
with previous 
lower limb 
amputations or 
those unable to fill 
out the 
questionnaire.  
 
Method  
 
Rate of phantom and 
stump pain were 
assessed at 8 days, 6 
weeks, and 3 months 
post-op using VAS 
scores.  
 
Block height, motor 
block, number of 
epidural bolus doses, 
respiratory rate, and 
presence of N/V were 
also recorded during 
epidural infusion 
period. 
 
SigmaState for 
Windows, chi-squared 
analysis, Fisher’s 
exact test, and 
ANOVA were used 
for data analysis.   
 
Outcome 
 
There was no 
addition 
reduction in 
persistent pain in 
the ketamine 
group versus the 
local anesthetic 
group at one 
year.  
 
There was a 
reduction of pain 
in the acute post-
operative period 
in the ketamine 
group. 
 
 
 
 
 
 
Note. VAS is defined as Visual Analogue Scale
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Table A.2  
Behdad, A., Hosseinpour, M., Khorasani, P. (2011). Preemptive use of ketamine on post-operative pain of appendectomy. 
The Korean Journal of Pain, 24(3), 137-140.  
Aim 
 
To evaluate 
whether the 
preemptive used 
of ketamine 
decreases post-
operative pain in 
patients 
undergoing 
appendectomy. 
Design 
 
Double blind, 
randomized 
clinical trial. 
 
Ketamine Group- 
0.5 mg/kg IV 
ketamine 10 min. 
prior to incision 
 
Control Group- 
0.5 mg/kg IV 
normal saline 10 
min. prior to 
incision 
 
 
Site 
 
Medical 
University of 
Isfahan, Trauma 
Research Center, 
Kashan University 
of Medical 
Sciences, Kashan, 
Iran.   
Sample 
 
80 adult male 
patients 
undergoing 
operations for 
acute appendicitis. 
 
40 patients in each 
group.  
 
Patients excluded 
with 
cardiovascular 
disease, 
hypertension, 
increased ICP, 
epilepsy, stroke, 
drug abuse of 
psychiatric 
disorders.  
 
 
Method  
 
Data was collected 
by performing 
assessments at T = 
0 (immediately 
after wake-up), 4, 
12 and 24 hours 
postoperatively 
using VAS*. 
 
Time to first 
requested 
analgesic and total 
number of times 
requests for 
additional 
analgesic were 
also recorded.  
Outcome 
 
Low-dose 
ketamine 
intravenously 
administered 
preemptively was 
effective in 
reducing post-
operative pain 
after 
appendectomies. 
 
 
 
 
Note. VAS is defined as Visual Analogue Scale. 
48 
 
Table A.3  
Ryu, H., Lee, C., Kim, Y., & Bahk, J. (2011). Preemptive low-dose epidural ketamine for preventing chronic 
postthoracotomy pain: a prospective double-blinded, randomized, clinical trial. Clinical Journal of Pain, 27(4), 304-208.   
Aim 
 
To assess the 
effect of 
preemptive low-
dose ketamine in 
addition to 
preemptive 
thoracic epidural 
analgesia on the 
incidence of 
chronic post-
thoracotomy pain. 
Design 
 
Prospective 
randomized, 
double-blind 
control trial. 
 
Group K- 0.12% 
levobupivacaine, 2 
mcg/mL fentanyl 
and 0.2 mg/ml 
ketamine for a 
total of 500 mL 
via epidural 
infusion 
 
Group KF- 0.12% 
levobupivacaine, 2 
mcg/ml fentanyl 
for a total of 500 
ml via epidural 
infusion 
 
Anesthesia and 
surgical technique 
was the same 
between groups. 
 
Site 
 
Seoul National 
University 
Hospital, Seoul, 
South Korea.  
Sample 
 
133 total patients 
were analyzed, 65 
in Group K, 68 in 
Group KF.  
 
Patients with a 
history of previous 
thoracotomy, 
neurological 
deficits, localized 
systemic 
infections or 
psychiatric disease 
were excluded.  
 
Method  
 
Pain at 
thoracotomy scar 
site was assessed 
at 2 weeks and 3 
months after 
surgery using 
VAS*.  
 
Also recorded was 
the incidence of 
allodynia and 
numbness.  
 
Statistical analysis 
was performed 
using Stata IC 10. 
Fisher’s exact test 
was also used to 
compare the 
incidence of 
chronic 
postthoracotomy 
pain.  
Procedure 
 
The addition of 
low-dose epidural 
ketamine to 
preemptive 
thoracic epidural 
analgesia does not 
affect the 
incidence of 
chronic 
postthoracotomy 
pain at 3 months 
after thoracotomy.  
 
 
 
 
 
Note. VAS is defined as Visual Analogue Scale.  
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Table A.4 
Singh, H., Kundra, S., Singh, R., Grewal, A., Kaul, T., & Sood, D. (2013). Preemptive analgesia with ketamine for a 
laparoscopic cholecystectomy. Journal of Anesthesiology Clinical Pharmacology, 29 (4), 478-484.  
Aim 
 
To evaluate 
preemptive 
analgesic efficacy 
of intravenous 
ketamine in 
patients 
undergoing 
laparoscopic 
cholecystectomy. 
Design 
 
Randomized, 
double-blind 
study. 
 
Group A- 
Ketamine 1.00 
mg/kg 
 
Group B- 
Ketamine 0.75 
mg/kg  
 
Group C- 
Ketamine 0.50 
mg/kg 
 
Group D- 10 mL 
isotonic saline 
 
All doses 
administered 30 
minutes prior to 
surgery. 
 
Site 
 
Dayanand Medical 
Hospital, 
Ludhiana, Punjab, 
India.  
Sample 
 
80 patients total, 
20 per group. .  
 
All patients 
undergoing 
laparoscopic 
surgery and ASA 
I-III. 
 
Patients with a 
history of drug 
abuse, unable to 
comprehend the 
VAS scale, 
psychiatric 
illnesses or 
communication 
difficulties were 
excluded. 
Method  
 
Pain assessed at 
time intervals 
post-op with the 
patient at rest, 
moving slightly, 
and deep breathing 
using VAS* 
scores.  
 
Time intervals 
were every 30 
minutes for 2 
hours, every hour 
for 4 hours, and at 
12 hours and 24 
hours. 
 
Requests for 
additional 
analgesia, adverse 
effects, and PONV 
were also 
recorded. 
Outcome 
 
Low-dose 
ketamine 
administered 
before surgical 
incision has 
preemptive effect 
on postoperative 
pain and reduced 
analgesic 
requirements 
during the first 24 
hours after a 
laparoscopic 
cholecystectomy. 
 
 
 
 
 
Note.VAS is defined as Visual Analogue Scale.  
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Table A.5 
Jennings, P., Cameron, P., Bernard, S., Walker, T., Jolley, D., Fitzgerald, M., & Masci, K. (2014). Long-term pain 
prevalence and health-related quality of life outcomes for patients enrolled in a ketamine versus morphine for prehospital 
traumatic pain randomized controlled trial. Emergency Medicine Journal, 31, 840-843. 
Aim 
 
Determine the 
prevalence of 
persistent pain and 
whether there 
were differences 
in patients who 
received ketamine 
or morphine. 
Design 
 
Prehospital, 
prospective, 
randomized 
controlled study, 
long-term follow-
up. 
 
Ketamine Group- 
20 mg IV bolus 
ketamine + 10 mg 
every 3 minutes 
until pain free 
 
Morphine Group- 
5 mg IV bolus 
morphine + 5 mg 
every 5 minutes 
until pain free 
 
Both groups were 
followed up with a 
phone interview 6-
12 months after 
study enrollment. 
Site 
 
Prehospital via 
Ambulance 
Victoria. Located 
in Melbourne, 
Australia.  
Sample 
 
97 total patients 
all with isolated 
musculoskeletal 
trauma and initial 
verbal pain score 
>5. 
 
70 patients 
enrolled in the 
ketamine group.  
 
65 patients 
enrolled in the 
morphine group.  
 
Patients with head 
injuries and LOC, 
or had presumed 
alcohol or drug 
intoxication were 
excluded. 
Method  
 
Data collected 
during telephone 
interviews with 3 
pain scales: Verbal 
Numerical Rating 
Scale, Physical 
Component 
Summary, Mental 
Component 
Summary  
 
Verbal Numerical 
Rating Scales 
were compared 
using Wilcoxon 
rank-sum test. 
 
Component 
Summary Scales 
were compared 
using the two-
sample t-test. 
Outcome 
 
Prevalence of pain 
was approximately 
the same in both 
study groups.  
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Table A.6  
Khashan, M., Dolkart, O., Amar, E., Chechik, O., Sharfman, Z., Mozes, G., Maman, E., & Weinbroum, A. (2016). Effect of 
preemptive intra-articular morphine and ketamine on pain after arthroscopic rotator cuff repair: a prospective, double-blind, 
randomized controlled study. Arthroscopy and Sports Medicine, 136, 233-239.  
Aim 
 
To compared the 
postoperative anti-
nociceptive effects 
of pre-incisional 
intra-articular 
ketamine when 
combined with 
morphine with 
two times the dose 
of morphine or 
saline. 
Design 
 
Prospective, 
randomized, 
double-blind 
study. 
 
Patients separated 
into 3 groups, 
treated 20 minutes 
prior to incision 
with sub-acromial 
injections. 
 
M Group- 
morphine 20 
mg/ml 
 
KM Group- 
ketamine 50 mg + 
morphine 10 
mg/ml 
 
S Group- 0.9% 
saline 10 ml 
 
 
Site 
 
Shoulder unit and 
post-operative 
care unit, Tel Aviv 
Medical Center, 
Tel Aviv, Israel.  
Sample 
 
52 patients 
enrolled total, 17 
in M Group, 19 in 
KM group, 16 in S 
group.  
 
All patients 
undergoing 
arthroscopic 
rotator cuff repair 
via general 
anesthesia. 
 
Patients with 
unrelated chronic 
pain issues, 
neuromuscular 
deficits, 
psychiatric illness, 
or major systemic 
disease were 
excluded. 
Method  
 
Patients were 
connected to an IV 
PCA to deliver 1.5 
mg morphine 
boluses.  
 
Pain NRS* and 
vitals were 
recorded every 30 
min. in PACU, 
every 8 hours on 
medical floor. 
 
Post-discharge 
pain levels and 
rescue drug 
consumption were 
reported using a 
daily PRN diary. 
 
Numeric scale 
parameters were 
compared between 
groups. 
Outcome 
 
The use of 
morphine alone 
provided 
consistent 
analgesic benefit 
when compared to 
the control group 
and in a greater 
benefit than the 
morphine and 
ketamine group.  
 
Not statistically 
significant. 
 
 
 
 
 
Note. NRS is defined as Numeric Rating Scale. 
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Table A.7 
Lin, H., & Jia, D. (2016). Effect of preemptive ketamine administration on postoperative visceral pain after gynecological 
laparoscopic surgery. Journal of Huazhong University of Science and Technology, 36(4), 584-587.   
Aim 
 
To determine the 
effects of 
preemptive 
ketamine on 
visceral pain in 
patients 
undergoing 
gynecological 
laparoscopic 
surgery. 
Design 
 
Prospective, 
randomized, 
double-blind 
study. 
 
Group 1- IV 0.9% 
saline, pre-
incision 
 
Group 2-  
IV 0.9% saline 
pre-incision, 20 
mL Ropivacaine 
via local 
infiltration at end 
of surgery 
 
Group 3-  
Ketamine 0.3 
mg/kg pre-
incision, 20 mL 
ropivacaine via 
local infiltration at 
end of surgery 
 
Site 
 
People’s Hospital 
of Henan 
Province, 
Zhengzhou, 
China. Peking 
University Third 
Hospital, Beijing, 
China.   
Sample 
 
88 total patients, 
29 in group 1, 29 
in group 2, 30 in 
group 3.  
 
Patients with 
preexisting 
neurological or 
psychiatric 
illnesses, patients 
with severe organ 
disease, patients 
with chronic pain 
or history of drug 
or alcohol abuse 
were excluded.  
Method  
 
Parietal and 
visceral pain 
assessed using the 
VAS* at 2, 6, 12, 
and 24 hours post-
op. Referred 
shoulder pain was 
also recorded.  
 
VAS scores above 
4, tramadol was 
administered 
followed by 
intramuscular 
injection of 
meperidine if no 
relief was 
achieved. 
 
Data compared 
between groups by 
analysis of 
variance, post-hoc 
testing and chi-
square tests. 
Outcome 
 
Preemptive 
ketamine was 
effective in 
controlling post-
operative visceral 
pain. 
  
 
 
 
 
 
Note. VAS is defined as Visual Analogue Scale   
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Appendix B  
Data Collection Tables 
Table B.1 
Wilson, J., Nimmo, A., Fleetwood-Walker, S., & Colvin, L. (2008). A randomized double blind trial of the effect of the pre-
emptive epidural ketamine on persistent pain after lower limb amputation. Pain, 135, 108-118. 
 Group K- stump pain  Group S- stump pain 
    VAS                                 %       VAS                                % 
8 days                           42                   65%  50                           58% 
6 weeks                              30            53%  40                            45% 
3 months 29                           33%  40                            43% 
6 months 50                           47%  40                            32% 
12 months 50                           21%  35                            33% 
    
 Group K- phantom pain  Group S- phantom pain 
    
8 days 60                         35%  37                              50% 
6 weeks 35                         59%  36                               45% 
3 months 40                         40%  43                               37% 
6 months 55                         40%  25                               19% 
12 months 30                         50%  55                              40% 
____________________________________________________________________________________________________
_______ 
Note. Data shown are VAS (visual analogue scale) scores followed by percentages of those experiencing pain over total 
number in the group at each time point for both groups for up to 12 months following surgery.  
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Table B.2 
Behdad, A., Hosseinpour, M., Khorasani, P. (2011). Preemptive use of ketamine on post-operative pain of appendectomy. 
The Korean Journal of Pain, 24(3), 137-140. 
 Ketamine Group  Control Group  P-value 
Time (hrs)       
0 4.5 ±1.0  6.6 ± 1.1  0.017 
4 4.7 ± 0.1  4.7 ± 1.0  0.045 
12 2.2 ± 1.1  3.5 ± 0.9  0.039 
24 1.3 ± 0.5  1.8 ± 0.6  0.044 
______________________________________________________________________________________________________ 
Note. Scores indicate Visual Analogue Score (VAS) in each group at the given time interval with reported standard deviations.  
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Table B.3 
Ryu, H., Lee, C., Kim, Y., & Bahk, J. (2011). Preemptive low-dose epidural ketamine for preventing chronic 
postthoracotomy pain: a prospective double-blinded, randomized, clinical trial. Clinical Journal of Pain, 27(4), 304-208.  
 Group K Group KF          P 
    
Pain at rest at 3 months 51% 43% 0.348 
    
Pain with movement at 3 
months 68% 74% 0.46 
    
Allodynia at 3 months 14% 6% 0.122 
    
Numbness at 3 months 32% 40% 0.182 
    
VAS at rest at 2 weeks 25 (0-75) 25 (0-75) 0.727 
    
VAS at rest at 3 months 0 (0-90) 0 (0-75) 0.644 
    
VAS with movement at 2 weeks 50 (0-100) 50 (0-100) 0.539 
    
VAS with movement at 3 
months 25 (0-90) 25 (0-75) 0.373 
 
 
____________________________________________________________________________________________________
_ 
Note. Data are proportions or median (range).  
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Table B.4 
Singh, H., Kundra, S., Singh, R., Grewal, A., Kaul, T., & Sood, D. (2013). Preemptive analgesia with ketamine for a 
laparoscopic cholecystectomy. Journal of Anesthesiology Clinical Pharmacology, 29 (4), 478-484. 
 # of doses of rescue analgesic  Mean time to the requirement of rescue analgesic 
Group A 4.55 2.1 
   
Group B 4.45 1.85 
   
Group C 4.25 1.98 
   
Group D 7.35 0.375 
 
 
 
____________________________________________________________________________________________________
__ 
Note. Mean time to the requirement of rescue analgesic measured in hours. Group A received 1.0 mg/kg ketamine IV. Group B 
received 0.75 mg/kg ketamine IV. Group C received 0.50 mg/kg ketamine IV. Group D received isotonic saline. 
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Table B.5 
Jennings, P., Cameron, P., Bernard, S., Walker, T., Jolley, D., Fitzgerald, M., & Masci, K. (2014). Long-term pain 
prevalence and health-related quality of life outcomes for patients enrolled in a ketamine versus morphine for prehospital 
traumatic pain randomized controlled trial. Emergency Medicine Journal, 31, 840-843 
      Physical Component Summary Score     Mental Component Summary Score 
 #         K + M Group M Group p Value   K + M Group M Group p Value 
Injury Severity Score        
0-4 77 49.1 47.8 0.61 49.2 49.4 0.94 
14-May 14 51.3 50.9 0.93 55.2 56.4 0.76 
15+ 6 37.8 44.9 0.62 46.4 45.5 0.94 
Initial Pain Score        
7-May 51 51.4 48.8 0.28 52 51.3 0.82 
10-Aug 46 46.1 47 0.82 47.7 48.6 0.84 
Final Pain Score        
0-4 68 49.1 49.2 0.98 50 49.6 0.92 
7-May 22 56.2 44.7 0.08 53.3 48.3 0.54 
10-Aug 7 30.9 53.4 0.03 45.3 57.7 0.12 
Prehospital Time        
<60  min.  68 48.4 48.6 0.94 50.5 48.6 0.57 
>60 min.  29 50.1 45.9 0.25 49.2 53.9 0.24 
Case Nature        
Extremity Fracture 33 47.1 48.7 0.61 47.2 52.3 0.28 
Soft Tissue Injury 26 52.5 48.2 0.41 52 48.9 0.56 
Fracture, other 21 47.8 45.6 0.64 49.5 47.2 0.73 
Dislocation 15 45.7 47 0.86 51        48.7 0.63 
Burn 2 58.4 59.6 NA 57.4 52.6 NA 
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Table B.6 
Khashan, M., Dolkart, O., Amar, E., Chechik, O., Sharfman, Z., Mozes, G., Maman, E., & Weinbroum, A. (2016). Effect of 
preemptive intra-articular morphine and ketamine on pain after arthroscopic rotator cuff repair: a prospective, double-blind, 
randomized controlled study. Arthroscopy and Sports Medicine, 136, 233-239. 
 M Group (n=17) KM Group (n=19) S Group (n= 17) P-value 
     
PACU 4.15 ± 0.51 5.29 ± 0.57 4.32 ± 0.43 0.25 
On Ward 3.37 ± 0.31 4.75 ± 0.43 4.71 ± 0.50 0.041* 
1st post-op week 4.93 ± 0.36 5.98 ± 0.61 6.83 ± 0.90 0.035* 
2nd post-op week 3.79 ± 0.45 5.44 ± 0.72 6.41 ± 0.57 0.013* 
3 months post-op 3.0 ± 0.56 4.0 ± 0.62 2.80 ± 0.40 0.25 
     
PCA morphine 21.6 ± 3.1 18.2 ± 2.9 17.3 ± 3.4 0.6 
Wk 1 - Paracetamol 0.76 ± 0.18 0.95 ± 0.17 1.0 ± 0.22 0.64 
Wk 1- Oxycodone 1.15 ± 0.25 1.7 ± 0.24 1.3 ± 0.29 0.26 
Wk 2- Paracetamol 0.52 ± 0.18 0.91 ± 0.2 0.94 ± 0.25 0.32 
Wk 2- Oxycodone 0.79 ±0.21 1.4 ± 0.56 1.15 ± 0.25 0.53 
 
Note. * indicates statistical difference between M and S group. M indicates group that received 20 mg/10 ml morphine. KM 
indicates group that received 50 mg ketamine and 10 mg/10 ml morphine. S indicates group that received 0.9% saline. All 
numbers are average pain scores obtained with Numeric Rating Scale with reported standard deviations.  
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Table B.7 
Lin, H., & Jia, D. (2016). Effect of preemptive ketamine administration on postoperative visceral pain after gynecological 
laparoscopic surgery. Journal of Huazhong University of Science and Technology, 36(4), 584-587.   
 Group 1  Group 2  Group 3 
Visceral Pain       
2 hours 6.2 ± 1.2  5.8 ± 1.8  3.1 ± 1.3 
6 hours 5.1 ± 1.1  5.2 ± 1.2  2.9 ± 1.2 
12 hours 3.1 ± 0.8  2.6 ± 0.6  2.5 ± 0.5 
24 hours 2.6 ± 1.0  2.5 ± 0.8  2.4 ± 0.8 
      
Incisional Pain       
2 hours 6.6 ± 2.0  3.3 ± 1.7  3.1 ± 1.6 
6 hours 5.1 ± 1.6  3.1 ± 1.5  2.8 ± 1.2 
12 hours 2.8 ± 1.5  2.7 ±1.4  2.6 ± 1.1 
24 hours 2.6 ± 1.5  2.7 ±1.6  2.4 ± 1.6 
      
Meperidine 23*  18*  18* 
Dose per pt (mg) 98 ± 17.5  52.5 ± 14.5  54.2 ± 16.4 
No analgesics       
required 6  11  12 
 
Note. * indicates number of people in the specified group that requested additional analgesic. All numbers are pain scores 
reported via Visual Analogue Scale and standard deviations.  
 
60 
 
Appendix C 
 
Critical Appraisal Skills Programme (CASP)  
 
Table C.1 
 
Wilson, J., Nimmo, A., Fleetwood-Walker, S., & Colvin, L. (2008). A randomized 
double blind trial of the effect of the pre-emptive epidural ketamine on persistent pain 
after lower limb amputation. Pain, 135, 108-118. 
A) Are the results of the trial valid? Yes Can’t Tell No 
1. Did the trial address a clearly focused issue? ✓   
2. Was the assignment of patients to treatments 
randomized? 
✓   
3. Were all the patients who entered the trial 
properly accounted for at its conclusion? 
         ✓           
4. Were patients, health workers and study 
personnel “blind” to treatment? 
        ✓            
5. Were the groups similar at the start of the 
trial? 
✓           
6. Aside from the experimental intervention, 
were the groups treated equally? 
✓   
B) What are the results? 
7. How large was the treatment effect?   
 
47 total patients assigned to treatment groups 
8. How precise was the estimate of the 
treatment effect? 
 
Box and whisker plots graphed VAS scores 
for stump and phantom pain at different time 
intervals. The incidence and frequency of 
pain was also recorded for each group.  
 
C) Will the results help locally? Yes Can’t Tell No 
9. Can the results be applied in your context?  
 
     ✓          
10. Were all clinically important outcomes 
considered? 
✓                    
11. Are the benefits worth the harms and costs?
    
✓   
Note. VAS indicates Visual Analogue Scale. 
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Table C.2 
 
Behdad, A., Hosseinpour, M., Khorasani, P. (2011). Preemptive use of ketamine on 
post-operative pain of appendectomy. The Korean Journal of Pain, 24(3), 137-140. 
A) Are the results of the trial valid? Yes Can’t Tell No 
1. Did the trial address a clearly focused issue? ✓   
2. Was the assignment of patients to treatments 
randomized? 
✓   
3. Were all the patients who entered the trial 
properly accounted for at its conclusion? 
         ✓           
4. Were patients, health workers and study 
personnel “blind” to treatment? 
        ✓            
5. Were the groups similar at the start of the 
trial? 
✓           
6. Aside from the experimental intervention, 
were the groups treated equally? 
      ✓  
B) What are the results? 
7. How large was the treatment effect?   
 
80 adult male patients assigned to 
treatment/control groups 
8. How precise was the estimate of the 
treatment effect? 
 
Using the VAS scale, pain scores collected at 
time 0, 4, 12, and 24 hours post-operatively. 
The time interval for first requested analgesia 
was also recorded.  
 
C) Will the results help locally? Yes Can’t Tell No 
9. Can the results be applied in your context?  
 
     ✓          
10. Were all clinically important outcomes 
considered? 
✓                                      
11. Are the benefits worth the harms and costs?
    
✓   
Note. VAS indicates Visual Analogue Scale.  
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Table C.3 
 
Ryu, H., Lee, C., Kim, Y., & Bahk, J. (2011). Preemptive low-dose epidural ketamine 
for preventing chronic postthoracotomy pain: a prospective double-blinded, 
randomized, clinical trial. Clinical Journal of Pain, 27(4), 304-208. 
A) Are the results of the trial valid? Yes Can’t Tell No 
1. Did the trial address a clearly focused issue? ✓   
2. Was the assignment of patients to treatments 
randomized? 
✓   
3. Were all the patients who entered the trial 
properly accounted for at its conclusion? 
         ✓           
4. Were patients, health workers and study 
personnel “blind” to treatment? 
        ✓            
5. Were the groups similar at the start of the 
trial? 
✓           
6. Aside from the experimental intervention, 
were the groups treated equally? 
✓   
B) What are the results? 
7. How large was the treatment effect?   
 
133 patients’ data were analyzed 
8. How precise was the estimate of the 
treatment effect? 
 
VAS scores were assessed during rest and 
movement at 2 weeks and 3 months after 
surgery. Allodynia and numbness at the scar 
site was also documented.  
C) Will the results help locally? Yes Can’t Tell No 
9. Can the results be applied in your context?  
 
             ✓  
10. Were all clinically important outcomes 
considered? 
         ✓           
11. Are the benefits worth the harms and costs?
    
✓   
Note. VAS indicates Visual Analogue Scale.  
 
63 
 
Table C.4 
 
Singh, H., Kundra, S., Singh, R., Grewal, A., Kaul, T., & Sood, D. (2013). Preemptive 
analgesia with ketamine for a laparoscopic cholecystectomy. Journal of Anesthesiology 
Clinical Pharmacology, 29 (4), 478-484. 
A) Are the results of the trial valid? Yes Can’t Tell No 
1. Did the trial address a clearly focused issue? ✓   
2. Was the assignment of patients to treatments 
randomized? 
✓   
3. Were all the patients who entered the trial 
properly accounted for at its conclusion? 
         ✓           
4. Were patients, health workers and study 
personnel “blind” to treatment? 
        ✓            
5. Were the groups similar at the start of the 
trial? 
✓           
6. Aside from the experimental intervention, 
were the groups treated equally? 
✓   
B) What are the results? 
7. How large was the treatment effect?   
 
80 patients assigned to treatment/control 
groups 
8. How precise was the estimate of the 
treatment effect? 
 
Mean VAS and VRS scores were graphed 
for trend analysis. Total opioid consumption 
and time to rescue analgesia were recorded 
and compared.  
 
C) Will the results help locally? Yes Can’t Tell No 
9. Can the results be applied in your context?  
 
     ✓          
10. Were all clinically important outcomes 
considered? 
✓                                      
11. Are the benefits worth the harms and costs?
    
✓   
Note. VAS indicates Visual Analogue Scale. VRS indicates Verbal Rating Scale.  
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Table C.5 
 
Jennings, P., Cameron, P., Bernard, S., Walker, T., Jolley, D., Fitzgerald, M., & Masci, 
K. (2014). Long-term pain prevalence and health-related quality of life outcomes for 
patients enrolled in a ketamine versus morphine for prehospital traumatic pain 
randomized controlled trial. Emergency Medicine Journal, 31, 840-843. 
A) Are the results of the trial valid? Yes Can’t Tell No 
1. Did the trial address a clearly focused issue? ✓   
2. Was the assignment of patients to treatments 
randomized? 
✓   
3. Were all the patients who entered the trial 
properly accounted for at its conclusion? 
✓           
4. Were patients, health workers and study 
personnel “blind” to treatment? 
         ✓   
5. Were the groups similar at the start of the 
trial? 
✓   
6. Aside from the experimental intervention, 
were the groups treated equally? 
✓   
B) What are the results? 
7. How large was the treatment effect?   
 
97 patients total, no difference in pain 
prevalence 
8. How precise was the estimate of the 
treatment effect? 
 
telephone interviews performed to obtain 
PCS and MCS scores 
C) Will the results help locally? Yes Can’t Tell No 
9. Can the results be applied in your context?  
 
     ✓   
10. Were all clinically important outcomes 
considered? 
                                 ✓ 
11. Are the benefits worth the harms and costs?
    
✓   
Note. Follow up was possible in 72% of patients. Authors did not have access to “time to 
treatment” information and felt that this was an important covariate that should have been 
collected.  
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Table C.6 
 
Khashan, M., Dolkart, O., Amar, E., Chechik, O., Sharfman, Z., Mozes, G., Maman, 
E., & Weinbroum, A. (2016). Effect of preemptive intra-articular morphine and 
ketamine on pain after arthroscopic rotator cuff repair: a prospective, double-blind, 
randomized controlled study. Arthroscopy and Sports Medicine, 136, 233-239. 
A) Are the results of the trial valid? Yes Can’t Tell No 
1. Did the trial address a clearly focused issue? ✓   
2. Was the assignment of patients to treatments 
randomized? 
✓   
3. Were all the patients who entered the trial 
properly accounted for at its conclusion? 
         ✓           
4. Were patients, health workers and study 
personnel “blind” to treatment? 
         ✓   
5. Were the groups similar at the start of the 
trial? 
✓   
6. Aside from the experimental intervention, 
were the groups treated equally? 
      ✓  
B) What are the results? 
7. How large was the treatment effect?   
 
30 patients assigned to treatment groups 
8. How precise was the estimate of the 
treatment effect? 
 
Pain scores were recorded at several time 
intervals following surgery and up to 3 
months post-operatively using NRS. Pain 
medicine consumption was also recorded.  
C) Will the results help locally? Yes Can’t Tell No 
9. Can the results be applied in your context?  
 
     ✓            
10. Were all clinically important outcomes 
considered? 
✓                                      
11. Are the benefits worth the harms and costs?
    
✓   
Note. NRS indicates Numeric Rating Scale.   
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Table C.7 
 
Lin, H., & Jia, D. (2016). Effect of preemptive ketamine administration on 
postoperative visceral pain after gynecological laparoscopic surgery. Journal of 
Huazhong University of Science and Technology, 36(4), 584-587.   
A) Are the results of the trial valid? Yes Can’t Tell No 
1. Did the trial address a clearly focused issue? ✓   
2. Was the assignment of patients to treatments 
randomized? 
✓   
3. Were all the patients who entered the trial 
properly accounted for at its conclusion? 
         ✓           
4. Were patients, health workers and study 
personnel “blind” to treatment? 
         ✓   
5. Were the groups similar at the start of the 
trial? 
✓   
6. Aside from the experimental intervention, 
were the groups treated equally? 
✓   
B) What are the results? 
7. How large was the treatment effect?   
 
88 patients assigned to treatment groups 
8. How precise was the estimate of the 
treatment effect? 
 
Assessment of post-operative pain and 
visceral pain using VAS scores. Total 
consumption of analgesics and side effects 
were also recorded.  
 
C) Will the results help locally? Yes Can’t Tell No 
9. Can the results be applied in your context?  
 
     ✓           
10. Were all clinically important outcomes 
considered? 
✓                                      
11. Are the benefits worth the harms and costs?
    
✓   
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Appendix D 
Cross Study Analysis Table 
Authors Route Dosing Results 
Wilson, 
Nimmo, 
Fleetwood-
Walker & 
Colvin 
(2008) 
Epidurally 
administered 
ketamine for 
lower limb 
amputations.  
Group K - 0.125% 
bupivacaine infusion with 
3.3 mg/kg/l ketamine. 
Group S - 0.125% 
bupivacaine with 
equivalent volume NaCl 
0.9%.  
Rates of phantom and 
stump pain did not differ 
between groups at any of 
assessments up to one year 
post-op. Number of 
analgesic drugs prescribed 
did not vary between 
groups 
Behdad, 
Hosseinpour 
& 
Khorasani 
(2011).  
Intravenously 
administered 
ketamine for 
acute 
appendicitis.  
Ketamine Group - 0.5 
mg/kg IV ketamine 10 
min. prior to incision. 
Control Group - 0.5 mg/kg 
IV normal saline 10 min. 
prior to incision 
Pain scores were 
significantly lower in 
Ketamine group. The 
control group asked for 
additional analgesic faster 
than the ketamine group 
and more often.  
Ryu, Lee, 
Kim & 
Bahk 
(2011).  
Epidurally 
administered 
ketamine for 
postthoracotomy 
pain.  
Group K - 0.12% 
levobupivacaine, 2 
mcg/mL fentanyl and 0.2 
mg/ml ketamine for a total 
of 500 mL via epidural 
infusion. Group KF - 
0.12% levobupivacaine, 2 
mcg/ml fentanyl for a total 
of 500 ml via epidural 
infusion. 
No difference in 
postthoracotomy pain at 3 
months between groups. 
No difference of allodynia 
or numbness incidence 
between groups.  
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Authors Context Participants/Groups Results 
Singh, 
Kundra, 
Singh, 
Grewal, 
Kaul & 
Sood 
(2017).  
Intravenously 
administered 
ketamine for 
patients 
undergoing 
laparoscopic 
cholecystectomy. 
Group A- Ketamine 1.00 
mg/kg. Group B- 
Ketamine 0.75 mg/kg. 
Group C- Ketamine 0.50 
mg/kg. Group D- 10 mL 
isotonic saline. All doses 
administered 30 minutes 
prior to surgery. 
Pain scores were 
highest in Group D at 
0 h post-op. Groups 
A, B, & C had 
decreased post-op 
pain scores at 0, 0.5, 
3, 4, 5, 6, & 12 h. 
Post-op analgesic 
consumption was less 
in groups A, B, & C. 
No significant 
difference in pain 
between groups A, B, 
& C.  
Jennings, 
Cameron, 
Bernard, 
Walker, 
Jolley, 
Fitzgerald 
& Masci 
(2014).  
Intravenously 
administered 
ketamine on 
hospital arrival 
for patients with 
musculoskeletal 
trauma.  
Ketamine Group- 20 mg 
IV bolus ketamine + 10 
mg every 3 minutes until 
pain free. Morphine 
Group- 5 mg IV bolus 
morphine + 5 mg every 
5 minutes until pain free.  
The prevalence of 
persistent pain was 
the same between 
groups. 
Khashan, 
Dolkart, 
Amar, 
Chechik, 
Sharfman, 
Mozes, 
Maman & 
Weinbroum 
(2016).  
Intra-articular 
ketamine for 
patients 
undergoing 
arthroscopic 
rotator cuff 
repair.  
M Group- morphine 20 
mg/ml. KM Group- 
ketamine 50 mg + 
morphine 10 mg/ml.  S 
Group- 0.9% saline 10 
ml 
24 h and 2 week pain 
scores were 
significantly lower in 
treatment groups 
compared to placebo, 
but did not 
significantly differ 
between the two. 
PCA-morphine and 
oral analgesics were 
consumed at similar 
rates among all 
groups.  
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Authors Context Participants/Groups Results 
Lin & Jia 
(2016).  
Intravenously 
administered 
ketamine on 
visceral pain for 
patients 
undergoing 
gynecological 
laparoscopic 
surgery. 
 Group 1- IV 0.9% 
saline, pre-incision. 
Group 2- IV 0.9% saline 
preincision, 20 mL 
Ropivacaine via local 
infiltration at end of 
surgery. Group 3- 
Ketamine 0.3 mg/kg 
preincision, 20 mL 
ropivacaine via local 
infiltration at end of 
surgery. 
Pain scores for group 
3 were significantly 
lower than groups 1 & 
2 at 2 h and 6 h post-
op. Groups 1 & 2 did 
not differ at 2 h and 6 
h post-op. All groups 
were not statistically 
different at 12 h and 
24 h post-op. 
Consumption of 
analgesics was 
significantly greater in 
group 1 than the other 
groups. The time for 
first analgesia request 
was significantly 
longer in groups 2 & 
3.  
       
 
 
 
